Our research laboratory is affiliated with the Department of Genetics and Development and the Herbert Irving Comprehensive Cancer Center at Columbia University Irving Medical Center. We employ high-throughput genetic and (epi)genomic technologies to understand the mechanisms by which misregulation of chromatin modifications drive tumor development. Our goal is to apply insights from mechanistic studies to develop novel precision medicine and immunotherapy for cancer.